Edition:
United Kingdom

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

36.12USD
19 Oct 2018
Change (% chg)

$-2.47 (-6.40%)
Prev Close
$38.59
Open
$38.99
Day's High
$39.50
Day's Low
$35.52
Volume
562,082
Avg. Vol
910,465
52-wk High
$52.52
52-wk Low
$2.14

Chart for

About

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System... (more)

Overall

Beta: 0.35
Market Cap(Mil.): $41.19
Shares Outstanding(Mil.): 50.23
Dividend: --
Yield (%): --

Financials

  TNDM.OQ Industry Sector
P/E (TTM): -- 32.10 33.65
EPS (TTM): -2.64 -- --
ROI: -120.44 13.82 14.28
ROE: -1,308.23 16.56 16.00

BRIEF-Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump

* TANDEM DIABETES CARE-ANNOUNCED RECEIPT OF CE MARK APPROVAL FOR T:SLIM X2 INSULIN PUMP WITH DEXCOM G5® MOBILE CONTINUOUS GLUCOSE MONITORING INTEGRATION

30 Apr 2018

BRIEF-Tandem Diabetes Care Files For Mixed Shelf Of Up To $100 Mln

* TANDEM DIABETES CARE INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING Source : https://bit.ly/2JtPqwk Further company coverage: (Reuters.Briefs@thomsonreuters.com)

26 Apr 2018

BRIEF-Tandem Diabetes Care Reports Qtrly Net Loss Per Share, Basic And Diluted Of $1.82

* TANDEM DIABETES CARE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

26 Apr 2018

BRIEF-Tandem Diabetes Care Announces Insulin Pump Products Distribution Agreements In Australia And New Zealand

* TANDEM DIABETES CARE SAYS ANNOUNCES AGREEMENTS FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN AUSTRALIA AND NEW ZEALAND Source text for Eikon: Further company coverage:

23 Apr 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $139.05 -0.45
Roche Holding Ltd. (ROG.S) CHF244.95 +6.40
Roche Holding Ltd. (RO.S) CHF245.20 +5.80
Insulet Corporation (PODD.OQ) $88.19 -1.91

Earnings vs. Estimates